MIMEDX GROUP, INC. financials

  1. Home
  2. Financials
  3. MDXG
MDXG CIK 0001376339

Source: EDGAR filings · Built 2026-06-02T03:32:16Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow — — 24.74M -19.45M -5.24M —
EBITDA 78.77M 64.91M 40.54M -10.68M -1.87M -38.54M
Working Capital 213.21M 146.29M 118.25M 90.64M 106.17M 101.45M
Net Debt -143.56M -79.40M -29.55M -12.07M -31.92M -41.68M
Gross Margin 82.56% 82.78% 83.01% 81.96% 83.63% 84.16%
Operating Margin 15.26% 16.87% 11.55% -5.50% -2.91% -18.29%
Net Margin 11.60% 12.16% 18.11% -11.27% -4.25% -19.85%
Return on Equity (ROE) 18.94% 21.97% 40.80% 167.87% -12542.68% 32856.00%
Return on Assets (ROA) 14.18% 16.07% 24.36% -17.61% -5.47% -24.39%
Current Ratio 4.32× 4.21× 3.57× 3.08× 3.51× 2.71×
Debt-to-Equity 0.09× 0.13× 0.37× -3.00× 672.76× -360.91×
Effective Tax Rate 26.69% 26.70% -120.15% -1.04% -2.05% 19.92%
Cash Conversion Ratio 1.52× 1.56× 0.46× 0.59× 0.19× 0.61×
Accruals Ratio -0.07× -0.09× 0.13× -0.07× -0.04× -0.09×
SBC % of Revenue 3.92% 4.85% 5.28% 4.23% 5.85% 6.19%
CapEx Coverage — — 13.13× -11.51× -0.61× —
Free Cash Flow Per Share — — $0.17 $-0.17 $-0.05 —

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 21.16× 34.36× 23.70× — — —
P/FCF — — 51.74× — — —
FCF Yield — — 1.93% — — —
EV / EBITDA 10.91× 20.55× 30.90× — — —
P/S 2.39× 4.05× 3.99× 1.18× 2.79× 4.06×
P/B 3.91× 7.32× 8.99× — 8244.25× —

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 418.63M 348.88M 321.48M 267.84M 242.02M 248.23M
Cost of Goods and Services Sold 73.01M 60.07M 54.63M 48.32M 39.63M 39.33M
Gross Profit 345.62M 288.81M 266.84M 219.53M 202.39M 208.90M
Research and Development Expense 15.10M 12.34M 12.66M 12.70M 9.93M 11.71M
Selling, General and Administrative Expense 266.19M 225.09M 211.12M 208.67M 194.85M 181.02M
Operating Income (Loss) 63.89M 58.87M 37.12M -14.73M -7.05M -45.40M
Income Tax Expense (Benefit) 17.68M 15.30M -36.81M 206.00K 247.00K -12.26M
Net Income (Loss) Attributable to Parent 48.58M 42.42M 58.23M -30.20M -10.29M -49.28M
Earnings Per Share, Basic $0.33 $0.29 $0.40 $-0.33 $-0.15 $-0.77
Weighted Average Number of Shares Outstanding, Basic 147.79M 146.98M 116.50M 112.91M 110.35M 108.26M
Earnings Per Share, Diluted $0.32 $0.28 $0.37 $-0.33 $-0.15 $-0.77
Weighted Average Number of Shares Outstanding, Diluted 149.72M 149.05M 145.96M 112.91M 110.35M 108.26M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 166.12M 104.42M 82.00M 65.95M 87.08M 95.81M
Assets, Current 277.47M 191.89M 164.26M 134.20M 148.52M 160.62M
Assets 342.65M 263.92M 239.05M 171.43M 187.93M 202.03M
Long-term Debt 18.00M 19.00M 50.00M 50.00M 50.00M 50.00M
Liabilities, Current 64.27M 45.59M 46.01M 43.56M 42.36M 59.16M
Long-term Debt, Excluding Current Maturities 16.47M 17.83M 48.10M 48.59M 48.13M 47.70M
Liabilities 86.11M 70.81M 96.33M 96.92M 95.35M 110.61M
Stockholders' Equity Attributable to Parent 256.55M 193.11M 142.72M -17.99M 82.00K -150.00K
Common Stock, Shares, Outstanding 148.09M 146.93M 146.23M 113.71M 111.93M 110.93M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 74.00M 66.20M 26.77M -17.89M -1.98M -30.26M
Payments to Acquire Property, Plant, and Equipment — — 1.99M 1.51M 3.22M —
Net Cash Provided by (Used in) Investing Activities -6.89M -9.58M -2.15M -2.66M -3.40M -4.55M
Payments for Repurchase of Common Stock 0 0 9.52M 0 0 900.00K
Net Cash Provided by (Used in) Financing Activities -5.41M -34.20M -8.57M -580.00K -3.35M 61.56M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MDXG CIK 0001376339), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CNM

Core & Main, Inc.

LTH

Life Time Group Holdings, Inc.

TEM

Tempus AI, Inc.